A turning point in therapy for ameloblastomas

Ameloblastoma is a benign but locally aggressive odontogenic neoplasm in the jaw and maxilla [1,2]. If untreated, these lesions can reach enormous sizes and sometimes pose an airway risk. Although most are nonmetastasizing, they frequently recur if not adequately resected [3]. The current standard therapy for ameloblastoma is complete bone resection (radical intervention) with an adequate margin of safety, which is classified as marginal or segmental osteotomy for the mandible, and partial or total maxillectomy for the maxilla [1,4].

Source: Oral Oncology - March 13, 2018 Category: Cancer & Oncology Authors: Masanobu Abe, Liang Zong, Takahiro Abe, Kazuto Hoshi Tags: Letter to the editor Source Type: research